2005, a pivotal year for Axis-Shield, with strong growth and profitability

My biotech part of my portfolio is fairly heavy biased towards OXB at the moment as I expect that to grow more dramatically in the short to medium term....

but you are right, one should be careful not to get ones fingers singed....

and agree, I wouldnt say I am a pure chartist by any stretch, just like looking at charts....

and not too bothered whether other chartists have made it to be a millionaire - just looking out for number 1 ;-)

best wishes,

RoL
>>>>----------------------->
no advice intended